Stem definition | Drug id | CAS RN |
---|---|---|
2832 | 59-43-8 |
Dose | Unit | Route |
---|---|---|
50 | mg | O |
50 | mg | P |
Property | Value | Reference |
---|---|---|
EoM (Fraction excreted unchanged in urine) | 90 % | Benet LZ, Broccatelli F, Oprea TI |
S (Water solubility) | 500 mg/mL | Bocci G, Oprea TI, Benet LZ |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 5.55 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 4.50 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 3 | Benet LZ, Broccatelli F, Oprea TI |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pemphigus | 1726.75 | 10.32 | 4403 | 535873 | 179323 | 62769423 |
Systemic lupus erythematosus | 1626.69 | 10.32 | 4671 | 535605 | 204247 | 62744499 |
Glossodynia | 1439.36 | 10.32 | 4048 | 536228 | 174828 | 62773918 |
Hand deformity | 1172.81 | 10.32 | 3495 | 536781 | 155962 | 62792784 |
Arthropathy | 1089.69 | 10.32 | 4416 | 535860 | 230376 | 62718370 |
Abdominal discomfort | 1010.41 | 10.32 | 5387 | 534889 | 315498 | 62633248 |
Alopecia | 1001.29 | 10.32 | 5575 | 534701 | 331961 | 62616785 |
Wound | 971.12 | 10.32 | 3327 | 536949 | 159936 | 62788810 |
Completed suicide | 941.64 | 10.32 | 80 | 540196 | 145593 | 62803153 |
Maternal exposure during pregnancy | 866.53 | 10.32 | 3939 | 536337 | 216123 | 62732623 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Rheumatoid arthritis | 507.39 | 10.27 | 832 | 196495 | 37406 | 34722198 |
Drug abuse | 379.79 | 10.27 | 54 | 197273 | 99042 | 34660562 |
Completed suicide | 302.93 | 10.27 | 89 | 197238 | 98079 | 34661525 |
Toxicity to various agents | 264.70 | 10.27 | 453 | 196874 | 199909 | 34559695 |
Foetal exposure during pregnancy | 240.34 | 10.27 | 609 | 196718 | 37492 | 34722112 |
Arthralgia | 214.87 | 10.27 | 1668 | 195659 | 168373 | 34591231 |
Psoriatic arthropathy | 180.11 | 10.27 | 366 | 196961 | 19432 | 34740172 |
Drug interaction | 145.68 | 10.27 | 718 | 196609 | 225228 | 34534376 |
Sickle cell anaemia with crisis | 132.91 | 10.27 | 138 | 197189 | 3915 | 34755689 |
Joint swelling | 124.60 | 10.27 | 667 | 196660 | 59223 | 34700381 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Completed suicide | 1190.55 | 10.08 | 163 | 563457 | 245604 | 78935164 |
Rheumatoid arthritis | 1153.30 | 10.08 | 3666 | 559954 | 204804 | 78975964 |
Toxicity to various agents | 934.64 | 10.08 | 961 | 562659 | 420579 | 78760189 |
Arthropathy | 911.98 | 10.08 | 3040 | 560580 | 174071 | 79006697 |
Pemphigus | 900.10 | 10.08 | 2099 | 561521 | 97483 | 79083285 |
Systemic lupus erythematosus | 885.86 | 10.08 | 2355 | 561265 | 118794 | 79061974 |
Joint swelling | 876.29 | 10.08 | 4199 | 559421 | 284447 | 78896321 |
Hand deformity | 866.59 | 10.08 | 2123 | 561497 | 101796 | 79078972 |
Synovitis | 832.39 | 10.08 | 2650 | 560970 | 148084 | 79032684 |
Glossodynia | 776.00 | 10.08 | 2029 | 561591 | 101308 | 79079460 |
None
Source | Code | Description |
---|---|---|
ATC | A11DA01 | ALIMENTARY TRACT AND METABOLISM VITAMINS VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 Vitamin B1, plain |
CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
CHEBI has role | CHEBI:75772 | S. cerevisiae metabolites |
CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
CHEBI has role | CHEBI:71692 | insect repellents |
MeSH PA | D018977 | Micronutrients |
MeSH PA | D014803 | Vitamin B Complex |
MeSH PA | D014815 | Vitamins |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Korsakoff's psychosis | indication | 69482004 | DOID:10915 |
Pernicious anemia | indication | 84027009 | DOID:13381 |
Vitamin deficiency | indication | 85670002 | |
Mineral deficiency | indication | 111379007 | |
Cobalamin deficiency | indication | 190634004 | |
Thiamin deficiency | indication | 399357009 | DOID:0070313 |
Vitamin Deficiency Prevention | indication | ||
Mineral Deficiency Prevention | indication | ||
Prevention of Vitamin B12 Deficiency | indication | ||
Methylmalonic acidemia | off-label use | 42393006 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.94 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Thiamine transporter 1 | Transporter | WOMBAT-PK | |||||||
Transketolase | Enzyme | WOMBAT-PK | |||||||
Thiamin pyrophosphokinase 1 | Kinase | WOMBAT-PK | |||||||
Thiamine-triphosphatase | Enzyme | WOMBAT-PK | |||||||
Transketolase-like protein 1 | Enzyme | WOMBAT-PK | |||||||
Heat shock protein HSP 90-alpha | Cytosolic other | IC50 | 4.90 | CHEMBL | |||||
Thiamine transporter ThiT | Transporter | Kd | 9.91 | CHEMBL |
ID | Source |
---|---|
VIB | PDB_CHEM_ID |
001061 | NDDF |
001062 | NDDF |
003860 | NDDF |
10454 | RXNORM |
1096 | MMSL |
1130 | PUBCHEM_CID |
126228004 | SNOMEDCT_US |
126229007 | SNOMEDCT_US |
15466 | MMSL |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
CitraNatal 90 DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0178-0821 | TABLET | 3 mg | ORAL | unapproved drug other | 11 sections |
CitraNatal 90 DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0178-0821 | TABLET | 4.54 mg | ORAL | unapproved drug other | 11 sections |
CitraNatal 90 DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0178-0821 | TABLET | 3 mg | ORAL | unapproved drug other | 11 sections |
CitraNatal 90 DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0178-0821 | TABLET | 4.54 mg | ORAL | unapproved drug other | 11 sections |
CitraNatal 90 DHA | HUMAN OTC DRUG LABEL | 14 | 0178-0829 | TABLET | 3 mg | ORAL | Unapproved drug other | 11 sections |
CitraNatal DHA | HUMAN OTC DRUG LABEL | 14 | 0178-0898 | TABLET | 3 mg | ORAL | Unapproved drug other | 11 sections |
CitraNatal Rx | HUMAN PRESCRIPTION DRUG LABEL | 13 | 0178-0858 | TABLET | 3 mg | ORAL | Unapproved drug other | 12 sections |
CitraNatal Rx | HUMAN PRESCRIPTION DRUG LABEL | 14 | 0178-0859 | TABLET | 3 mg | ORAL | Unapproved drug other | 9 sections |
Marnatal F | HUMAN PRESCRIPTION DRUG LABEL | 13 | 0682-1570 | CAPSULE | 3 mg | ORAL | UNAPPROVED DRUG OTHER | 4 sections |
NataFort | HUMAN PRESCRIPTION DRUG LABEL | 10 | 0178-0716 | TABLET | 2 mg | ORAL | Unapproved drug other | 12 sections |